USA

The FDA is supporting Moderna and J & J boosters because they have no problems mixing Covid vaccines.US news

U.S. regulators approved the extension of the Covid-19 booster to Americans vaccinated with Moderna or Johnson & Johnson on Wednesday, giving anyone eligible for additional doses a brand different from the one originally received. Said it was available.

The Food and Drug Administration’s (FDA) decision marks a major step towards expanding the US booster campaign, which began with an additional dose of Pfizer vaccine last month.

But before more people roll up their sleeves, the US Centers for Disease Control and Prevention (CDC) consults with a panel of experts later this week to finalize official recommendations on who should get boosters and when. increase.

The latest move has expanded the number of Americans targeted for boosters by tens of millions and officially allows “mixing and matching” of shots. This had side effects, especially one brand, but still proven protection of vaccination.

Specifically, six months after the last shot, the FDA will give a third Moderna shot to seniors and other people at high risk for Covid-19 due to health problems, work, or living conditions. approved. One big change: Moderna’s booster will be half the dose used for the first two shots, based on company data showing that it was enough to boost immunity again.

For J & J’s one-shot vaccine, the FDA stated that all US recipients should receive a second dose at least two months after the first vaccination.

FDA decisions differ due to different vaccine manufacturing methods and dosing schedules. In addition, the J & J vaccine has consistently shown lower levels of efficacy than the two-shot Moderna and Pfizer vaccines.

The FDA is supporting Moderna and J & J boosters because they have no problems mixing Covid vaccines.US news

Source link The FDA is supporting Moderna and J & J boosters because they have no problems mixing Covid vaccines.US news

Back to top button